The latest immunotherapy news and developments
Developing safe and efficient bioformulations using approved materials and ingenious designs can accelerate the clinical…
Researchers of McMaster University and the University of Toronto, Canada, have developed a promising immunotherapy…
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumour growth…
Scientists at Sanford Burnham Prebys, USA, have discovered that combining immunotherapy with a drug called…
Merck has announced positive results from the Phase 3 KEYNOTE-355 trial investigating pembrolizumab in combination with…
Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic…
Activating two different types of immune cells at the same time has been shown to…
QIMR Berghofer scientists are urging Queenslanders who have recovered from COVID-19 to help them discover…
A clinical trial led by Mount Sinai researchers in the US has showed for the…
For the first time in over a decade, scientists have identified a first-line treatment that…